85 related articles for article (PubMed ID: 2789384)
1. Does paraquat (PQ) mimic MPP+ toxicity?
Woolley DE; Gietzen DW; Gee SJ; Magdalou J; Hammock BD
Proc West Pharmacol Soc; 1989; 32():191-3. PubMed ID: 2789384
[No Abstract] [Full Text] [Related]
2. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Heikkila RE; Nicklas WJ; Duvoisin RC
Adv Neurol; 1987; 45():149-52. PubMed ID: 3103384
[No Abstract] [Full Text] [Related]
4. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
[TBL] [Abstract][Full Text] [Related]
5. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
Riachi NJ; Harik SI; Kalaria RN; Sayre LM
J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
[TBL] [Abstract][Full Text] [Related]
7. Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse.
Perry TL; Yong VW; Wall RA; Jones K
Neurosci Lett; 1986 Sep; 69(3):285-9. PubMed ID: 3489912
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes as a primary locus for the conversion MPTP into MPP+.
Brooks WJ; Jarvis MF; Wagner GC
J Neural Transm; 1989; 76(1):1-12. PubMed ID: 2785159
[TBL] [Abstract][Full Text] [Related]
9. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
Irwin I; Langston JW; DeLanney LE
Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
[TBL] [Abstract][Full Text] [Related]
10. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.
Booth RG; Castagnoli N; Rollema H
Neurosci Lett; 1989 May; 100(1-3):306-12. PubMed ID: 2788253
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
Sershen H; Mason MF; Debler EA; Lajtha A
Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
[TBL] [Abstract][Full Text] [Related]
12. Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens.
Barbeau A; Dallaire L; Buu NT; Poirier J; Rucinska E
Life Sci; 1985 Oct; 37(16):1529-38. PubMed ID: 3876500
[TBL] [Abstract][Full Text] [Related]
13. MPTP, MPP+ and mitochondrial function.
Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE
Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899
[TBL] [Abstract][Full Text] [Related]
14. Neuropathological lesions after microinfusion of paraquat and MPP+ into different areas of the rat brain.
Iannone M; Calò M; Rispoli V; Sancesario G; Nisticò G
Acta Neurol (Napoli); 1988 Dec; 10(6):313-21. PubMed ID: 3265850
[No Abstract] [Full Text] [Related]
15. Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicity.
Frank DM; Arora PK; Blumer JL; Sayre LM
Biochem Biophys Res Commun; 1987 Sep; 147(3):1095-104. PubMed ID: 3499150
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent.
Johannessen JN; Adams JD; Schuller HM; Bacon JP; Markey SP
Life Sci; 1986 Feb; 38(8):743-9. PubMed ID: 3485234
[TBL] [Abstract][Full Text] [Related]
17. Tissue culture model for studying MPTP toxicity to dopamine neurons.
Mytilineou C; Cohen G
Adv Neurol; 1987; 45():145-8. PubMed ID: 3493622
[No Abstract] [Full Text] [Related]
18. Reduction of muscarinic cholinergic receptors in mouse striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its recovery by levodopa treatment.
Ogawa N; Sora YH; Sato H; Mizukawa K
Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):133-6. PubMed ID: 3499644
[TBL] [Abstract][Full Text] [Related]
19. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
Algeri S; Ambrosio S; Garofalo P; Gerli P
Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067
[TBL] [Abstract][Full Text] [Related]
20. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
Chan P; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
